1702 – Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation Closed
  • Pre-MSAC consultation Closed
  • Outcome Supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Magnetic Resonance Imaging (MRI) of the abdomen using gadolinium-based contrast, performed for the surveillance of patients with a confirmed clinical and/or molecular diagnosis of a condition known to carry an increased risk of the development of renal tumours.

Type: Investigative technology

Medical condition this application addresses

A renal tumor is an abnormal growth in the kidney. Some renal masses are benign (not cancerous) and some are malignant (cancerous). A number of rare defined genetic conditions are strongly associated with the development of renal tumours over time. This includes (but is not limited to) Tuberous Sclerosis Complex, Von Hippel-Lindau disease, Birt-Hogg –Dube syndrome, hereditary leimyomatosis and renal cell cancer, Cowden syndrome, BAP1-associated cancer syndrome and paraganglioma. The commonest condition in this group of disorders is Tuberous Sclerosis Complex.

Consultation survey and deadlines

  • PASC consultation: Closed
  • MSAC consultation: Closed Friday 10 February 2023

Meetings to consider this application

  • PASC meeting: 13–14 April 2022
  • ESC meeting: 9–10 February 2023
  • MSAC meeting: 30–31 March 2023